Close

Abiomed (ABMD) Announces Large, Multi-Center, Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/15/2024

1. SPY
2. TSLA
3. RDDT
4. TCS:IN
5. ALAB
6. C
7. JPM
8. GS
9. AAPL
10. SCHW


Go back to Abiomed (ABMD) Announces Large, Multi-Center, Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81%
Abiomed, Inc. (NASDAQ: ABMD) Delayed: 381.02 --0 (-0%)
Previous Close $381.02    52 Week High $132.95 
Open $381.02    52 Week Low $67.81 
Day High $381.02    P/E 2,116.78 
Day Low $381.02    EPS $0.18 
Volume 4,595,555